🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07573501
Starting soon Not applicable

Dual-site Cross-frequency Coupled Transcranial Electrical Stimulation Modulates Working Memory of Patients With Post-stroke Cognitive Impairment

NCT07573501 · tracked via the Priya Life Science China tracker
Sponsor
Ke Dong, MD
Phase
Not applicable
Started
2026-05-01
Last updated
2026-05-11

Condition(s) studied

StrokeCognition Disorders

Investigational drug(s) / intervention(s)

occupational therapyreal tACSsham tACS

occupational therapy: occupational therapy (especially cognitive therapy) 40min a day for 5 days

real tACS: real theta-gamma CFC tACS for 40min a day for 5 days during cognitive therapy

sham tACS: sham theta-gamma CFC tACS for 40min a day for 5 days during cognitive therapy

Study summary

This clinical trial aims to explore the effect of dual-site theta-gamma cross-frequency coupled transcranial alternating current stimulation in the frontal and parietal region on the working memory ability of patients with cognitive impairment after stroke, and to evaluate the safety of this protocol. The main purpose is to answer the following question: Can dual-site cross-frequency coupled tACS in the frontal parietal region improve the performance of working memory and cognitive-motor dual tasks in stroke patients? What is its mechanism of action? Researchers will compare the effects of real cross-frequency coupled stimuli and sham stimuli to see if the real stimuli can bring better results to patients. Participants will receive 40 minutes of real or sham electrical stimulation once a day for 5 consecutive days. Clinical evaluations (cognitive scales) and fNIRS were conducted respectively before and after stimulation to record the relevant brain activities at rest and during cognitive tasks

Eligibility

Sex
ALL
Min age
30 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Meeting the diagnostic criteria for hemorrhagic or ischemic stroke in the Chinese Guidelines for the Prevention and Treatment of Cerebrovascular Diseases(2nd edition), with the first onset, single hemisphere stroke, and confirmed by CT or MRI,course of diease 1-6 months; * Age ranging from 30 to 80 years old; * Native language is Mandarin or Cantonese; * Right-handed; * Diagnosed with PSCI by the MoCA scale; * Able to cooperate in completing the speech repetition test; * Normal hearing. Exclusion Criteria: * Currently receiving non-invasive brain stimulation treatment; * Lesions involving the left DLPFC brain regions; * History of epilepsy, mental illness,or other neurological or mental disorders; * Any contraindications for transcranial electrical stimulation.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Rehabilitation Medicine, The First Affiliated Hospital, Sun Yat-sen University Guangzhou Guangdong

More Ke Dong, MD trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07573501 on ClinicalTrials.gov ↗ ← All trials in China